PATENT CLAIM ANALYSIS

Application Number: 15767618
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "231100"]

Abstract:
The disclosure relates to herpes simplex virus (HSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Claim (Index 71):
A pharmaceutical composition for use in vaccination of a subject comprising an effective dose of mRNA encoding a herpes simplex virus (HSV) antigen,\n wherein the effective dose is sufficient to produce a 1,000-10,000 neutralization titer produced by neutralizing antibody against said antigen as measured in serum of the subject at 1-72 hours post administration.

Metadata:
- Claim Count in Document: 70.0
- Percentile: 91.0
- Lexical Diversity: 1.24
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15674585', '15674591', '15674599', '15674569', '15091123']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7282389652407295
- 35 USC 102 Novelty (BERT): 0.5673536090399975
- Combined Prediction Score: 0.7121504296206563
- Mean Citation Score: 413.72095800000005
- Max Citation Score: 439.89752
- Similarity Product: 396.9062650925826

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test